ICANDRA Trademark
Trademark Overview
On Friday, January 11, 2002, a trademark application was filed for ICANDRA with the United States Patent and Trademark Office. The USPTO has given the ICANDRA trademark a serial number of 78102177. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, October 30, 2005. This trademark is owned by Novartis AG. The ICANDRA trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations for the treatment of disorders of the central nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, for the treatment of inflammatory disorders, for use in dermatology, oncology, and ophthalmology
General Information
| Serial Number | 78102177 |
| Word Mark | ICANDRA |
| Filing Date | Friday, January 11, 2002 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Sunday, October 30, 2005 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 6, 2002 |
Trademark Statements
| Goods and Services | pharmaceutical preparations for the treatment of disorders of the central nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, for the treatment of inflammatory disorders, for use in dermatology, oncology, and ophthalmology |
| Pseudo Mark | I CAN DRA |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, February 2, 2002 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Basel
CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Basel
CH |
Trademark Events
| Event Date | Event Description |
| Thursday, January 5, 2006 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Thursday, January 5, 2006 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, April 26, 2005 | EXTENSION 5 GRANTED |
| Tuesday, April 26, 2005 | EXTENSION 5 FILED |
| Tuesday, April 26, 2005 | TEAS EXTENSION RECEIVED |
| Tuesday, February 8, 2005 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Sunday, December 19, 2004 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, December 6, 2004 | PAPER RECEIVED |
| Monday, November 1, 2004 | EXTENSION 4 GRANTED |
| Wednesday, October 20, 2004 | EXTENSION 4 FILED |
| Wednesday, October 20, 2004 | TEAS EXTENSION RECEIVED |
| Monday, April 26, 2004 | ASSIGNED TO EXAMINER |
| Thursday, April 22, 2004 | EXTENSION 3 GRANTED |
| Monday, April 12, 2004 | EXTENSION 3 FILED |
| Friday, April 16, 2004 | CASE FILE IN TICRS |
| Monday, April 12, 2004 | TEAS EXTENSION RECEIVED |
| Tuesday, September 16, 2003 | EXTENSION 2 GRANTED |
| Tuesday, September 9, 2003 | EXTENSION 2 FILED |
| Tuesday, September 9, 2003 | TEAS EXTENSION RECEIVED |
| Wednesday, August 27, 2003 | EXTENSION 1 GRANTED |
| Wednesday, April 9, 2003 | EXTENSION 1 FILED |
| Monday, June 30, 2003 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, April 9, 2003 | TEAS EXTENSION RECEIVED |
| Tuesday, October 29, 2002 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 6, 2002 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 17, 2002 | NOTICE OF PUBLICATION |
| Tuesday, April 23, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, April 23, 2002 | ASSIGNED TO EXAMINER |
